Sun Pharma to Acquire Taro Pharmaceutical Industries in Definitive Merger Agreement
The agreement outlines Sun Pharma's acquisition of all outstanding ordinary shares of Taro, excluding those already held by Sun Pharma or its affiliates.
Global Pharma | 19/01/2024 | By Manvi
Hoth Therapeutics Receives FDA Clearance for Protocol Amendments in HT-001 Clinical Trial
The drug is being developed as a potential treatment for cancer patients experiencing skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors (EGFRI).
Global Pharma | 19/01/2024 | By Manvi
LogiPharma Launches 2024 Agenda Featuring Big Pharma Players
LogiPharma has unveiled its highly anticipated 2024 agenda, spotlighting key themes and speakers for this year's show, which takes place in Lyon, France, 16th – 18th April.
Global Pharma | 19/01/2024 | By Manvi
Union Cabinet Approves MoI Between India's CDSCO and Netherlands
The MoI, signed on 7th November 2023, sets the stage for collaborative efforts in the field of Medical Products Regulation.
Global Pharma | 19/01/2024 | By Manvi
The agreement aims to promote the exchange of information and collaboration in areas related to medical products, as well as administrative and regulatory matters within the jurisdictions of both parties.
Global Pharma | 19/01/2024 | By Manvi
Technical Drying Services Celebrates 25 Years of Empowering Industries
On the occasion of the silver jubilee, the company pledged to boost its innovative endeavors to amplify its leadership position in providing quality air solutions.
Global Pharma | 18/01/2024 | By Manvi
Bayer and Sun Pharma Sign Marketing Agreement for Second Brand of Finerenone in India
Under the terms of the agreement, Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.
Global Pharma | 18/01/2024 | By Manvi | 172
Torque Pharma Unveiles Transformative Brand Identity Under the Theme 'Better Together'
This strategic rebranding, initiated in 2024 with a fresh team and forward vision, signifies Torque Pharma's commitment to fostering collaboration, synergy, and unity in delivering innovative and high-quality healthcare solutions. The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme.
Global Pharma | 18/01/2024 | By Manvi
Asia-Pacific Pharmaceutical Logistics Market Set to Surge at 6.68 Percent CAGR
According to a comprehensive analysis, the market size is anticipated to swell from USD 143.22 billion in 2023 to an impressive USD 197.94 billion by 2028.
Global Pharma | 17/01/2024 | By Manvi
First US VasQ Implantation Signals Breakthrough in Vascular Access Surgery
VasQ™, a nitinol-based external support device, plays a crucial role in the surgical creation of an arteriovenous fistula to facilitate maturation into functional access for hemodialysis.
Global Pharma | 17/01/2024 | By Manvi
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy